NYSE:QGEN Qiagen (QGEN) Stock Price, News & Analysis $45.13 +0.13 (+0.29%) Closing price 03:59 PM EasternExtended Trading$45.14 +0.00 (+0.01%) As of 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Qiagen Stock (NYSE:QGEN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Qiagen alerts:Sign Up Key Stats Today's Range$44.78▼$45.4150-Day Range$38.24▼$44.9152-Week Range$37.63▼$49.30Volume1.60 million shsAverage Volume1.16 million shsMarket Capitalization$10.03 billionP/E Ratio125.66Dividend Yield0.55%Price Target$48.42Consensus RatingHold Company OverviewQIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.Read More… Qiagen Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks65th Percentile Overall ScoreQGEN MarketRank™: Qiagen scored higher than 65% of companies evaluated by MarketBeat, and ranked 361st out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingQiagen has received a consensus rating of Hold. The company's average rating score is 2.30, and is based on 3 buy ratings, 7 hold ratings, and no sell ratings.Amount of Analyst CoverageQiagen has only been the subject of 2 research reports in the past 90 days.Read more about Qiagen's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth8.85% Earnings GrowthEarnings for Qiagen are expected to grow by 8.85% in the coming year, from $2.26 to $2.46 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Qiagen is 125.08, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.17.Price to Earnings Ratio vs. SectorThe P/E ratio of Qiagen is 125.08, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.99.Price to Earnings Growth RatioQiagen has a PEG Ratio of 2.39. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioQiagen has a P/B Ratio of 2.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Qiagen's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted2.81% of the float of Qiagen has been sold short.Short Interest Ratio / Days to CoverQiagen has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in Qiagen has recently increased by 20.24%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldQiagen has a dividend yield of 0.59%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthQiagen does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Qiagen is 62.50%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Qiagen will have a dividend payout ratio of 10.16% next year. This indicates that Qiagen will be able to sustain or increase its dividend.Read more about Qiagen's dividend. Sustainability and ESG4.5 / 5Environmental Score-0.83 Percentage of Shares Shorted2.81% of the float of Qiagen has been sold short.Short Interest Ratio / Days to CoverQiagen has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in Qiagen has recently increased by 20.24%, indicating that investor sentiment is decreasing significantly. News and Social Media2.8 / 5News Sentiment1.08 News SentimentQiagen has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Qiagen this week, compared to 7 articles on an average week.Search InterestOnly 1 people have searched for QGEN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Qiagen insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.00% of the stock of Qiagen is held by insiders.Percentage Held by Institutions70.00% of the stock of Qiagen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Qiagen's insider trading history. Receive QGEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Qiagen and its competitors with MarketBeat's FREE daily newsletter. Email Address QGEN Stock News HeadlinesContrasting Genfit (NASDAQ:GNFT) and Qiagen (NYSE:QGEN)May 28 at 1:17 AM | americanbankingnews.comQiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology ResearchMay 26, 2025 | finance.yahoo.comEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.May 30, 2025 | Timothy Sykes (Ad)Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology ResearchMay 25, 2025 | insidermonkey.comQIAGEN expands digital PCR oncology research portfolio through partnership with ID SolutionsMay 22, 2025 | businesswire.comSome Investors May Be Willing To Look Past Qiagen's (NYSE:QGEN) Soft EarningsMay 16, 2025 | finance.yahoo.comQiagen Beats Earnings, But Its Expensive Valuation Caps Upside PotentialMay 16, 2025 | seekingalpha.comBlackRock Increases Stake in Qiagen, Influencing Market DynamicsMay 14, 2025 | tipranks.comSee More Headlines QGEN Stock Analysis - Frequently Asked Questions How have QGEN shares performed this year? Qiagen's stock was trading at $43.2931 at the start of the year. Since then, QGEN stock has increased by 3.7% and is now trading at $44.8980. View the best growth stocks for 2025 here. How were Qiagen's earnings last quarter? Qiagen (NYSE:QGEN) released its quarterly earnings results on Wednesday, May, 7th. The company reported $0.55 EPS for the quarter, topping the consensus estimate of $0.50 by $0.05. The business's revenue for the quarter was up 5.2% compared to the same quarter last year. Read the conference call transcript. When did Qiagen's stock split? Qiagen's stock split on Wednesday, January 29th 2025. The 36-35 split was announced on Wednesday, January 22nd 2025. The newly created shares were distributed to shareholders after the market closes on Tuesday, January 28th 2025. An investor that had 100 shares of stock prior to the split would have 103 shares after the split. Who are Qiagen's major shareholders? Qiagen's top institutional shareholders include Massachusetts Financial Services Co. MA (11.38%), Wellington Management Group LLP (10.99%), Vanguard Group Inc. (3.99%) and Deutsche Bank AG (2.02%). How do I buy shares of Qiagen? Shares of QGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Qiagen own? Based on aggregate information from My MarketBeat watchlists, some other companies that Qiagen investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Netflix (NFLX), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and PayPal (PYPL). Company Calendar Last Earnings5/07/2025Today5/30/2025Next Earnings (Estimated)7/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNYSE:QGEN CIK1015820 Webwww.qiagen.com Phone(177) 355-6600Fax31-77-355-6658Employees6,030Year FoundedN/APrice Target and Rating Average Stock Price Target$48.42 High Stock Price Target$52.50 Low Stock Price Target$43.00 Potential Upside/Downside+7.8%Consensus RatingHold Rating Score (0-4)2.30 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$0.40 Trailing P/E Ratio125.04 Forward P/E Ratio19.87 P/E Growth2.39Net Income$83.59 million Net Margins4.23% Pretax Margin6.12% Return on Equity13.92% Return on Assets8.40% Debt Debt-to-Equity Ratio0.38 Current Ratio3.61 Quick Ratio3.09 Sales & Book Value Annual Sales$2.00 billion Price / Sales4.98 Cash Flow$3.74 per share Price / Cash Flow12.01 Book Value$16.08 per share Price / Book2.79Miscellaneous Outstanding Shares222,291,000Free Float201,892,000Market Cap$9.98 billion OptionableOptionable Beta0.67 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NYSE:QGEN) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qiagen Please log in to your account or sign up in order to add this asset to your watchlist. Share Qiagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.